Journal article

SABR versus conventional fractionation regimens in NSCLC – Authors' reply

D Ball, A Herschtal

Lancet Oncology | ELSEVIER SCIENCE INC | Published : 2019

DOI: 10.1016/S1470-2045(19)30232-3

University of Melbourne Researchers

David Ball Author

Citation metrics

1Web of Science

Keywords

3211 Oncology and Carcinogenesis

Science & Technology

32 Biomedical and Clinical Sciences

Life Sciences & Biomedicine